Difference between revisions of "Girard TD, et al, N Engl J Med (2018), cited as Ref 79 in DOI: 10.1186/s13054-020-02882-x (Q10710)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): N Engl J Med, #quickstatements; #temporary_batch_1592746890515) |
(Created claim: publication URL (P92): https://doi.org/10.1056/NEJMoa1808217, #quickstatements; #temporary_batch_1592747250377) |
||
| Property / publication URL | |||
| + | |||
| Property / publication URL: https://doi.org/10.1056/NEJMoa1808217 / rank | |||
| + | Normal rank | ||
Latest revision as of 13:47, 21 June 2020
Cited in: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic" Research article in Crit Care; 2020 04 28 ; 24 (1) 176
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Girard TD, et al, N Engl J Med (2018), cited as Ref 79 in DOI: 10.1186/s13054-020-02882-x
|
Cited in: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic" Research article in Crit Care; 2020 04 28 ; 24 (1) 176
|
Statements
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness (English)
0 references
2018
0 references
Girard TD
0 references
Exline MC
0 references
Carson SS
0 references
N Engl J Med
0 references
